Skip to main content
Clinical Trials/NL-OMON41823
NL-OMON41823
Completed
Not Applicable

Quantification of pulmonary vascular remodelling in pulmonary arterial hypertension patients using positron emission tomography - Quantification of pulmonary vascular remodelling in PAH using PET

Vrije Universiteit Medisch Centrum0 sites8 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
high blood pressure in the pulmonary circulation
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
8
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Idiopathic pulmonary arterial hypertension

Exclusion Criteria

  • Left sided heart failure
  • Congenital heart disease

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
Pulmonary Vascular Hemodynamics Before and After Mitral Valve ProceduresPulmonary Hypertension
NCT04947384University of Alabama at Birmingham120
Recruiting
Not Applicable
on-invasive assessment of lung remodeling in patients with idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) using [11C]-Nintedanib or [18F]-FLT PET imaging.
NL-OMON44254Vrije Universiteit90
Active, not recruiting
Not Applicable
Characteristics of Pulmonary Vascular Changes in Patients With Kidney TransplantationPulmonary HypertensionKidney TransplantationHaemodialysis
NCT04842591Medical University of Graz60
Completed
Not Applicable
Clinicopathological study on the pulmonary vasculopathy and cardiac dysfunction in pulmonary hypertensiopulmonary hypertension, interstitial lung disease, chronic obstructive pulmonary disease
JPRN-UMIN000047417Hokkaido University17
Active, not recruiting
Phase 1
Can we predict a serious medical condition in the newborn by using an oxygen test, given to the mother when she is undergoing a fetal ultrasound scaPersistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occurs when there is a failure of the normal circulatory transition in the early newborn period. Persistence of the fetal circulation occurs,resulting in pulmonary hypertension,low oxygen levels and marked right-to-left shunting of blood in the newborn heart. Mortality ranges from 4 to 33%.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Investigative Techniques [E05]
EUCTR2016-003181-12-IERoyal College of Surgeons in Ireland60